SCHEMBL6092583

SCHEMBL6092583

CCCC(CO)Nc1cc(C)ccn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.50
ALDH1A1 P00352 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
KMT2A Q03164 2/20 0.46
TLR8 Q9NR97 3/20 0.43
TLR7 Q9NYK1 2/20 0.43
KDM4E B2RXH2 2/20 0.42
HPGD P15428 1/20 0.42
NOS2 P35228 1/20 0.41
NPC1 O15118 1/20 0.40
PKM P14618 1/20 0.40
RAB9A P51151 1/20 0.40
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
TEAD4 Q15561 1/20 0.39
KCNH2 Q12809 2/20 0.39
LMNA P02545 2/20 0.39
P4HB P07237 1/20 0.38
TAS1R3 Q7RTX0 1/20 0.38
TAS1R1 Q7RTX1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25059409 0.91 FDPS (0.51) FDPSALDH1A1SMN1; SMN2KMT2AKDM4E
SCHEMBL19879709 0.88 FDPS (0.53) FDPSALDH1A1SMN1; SMN2KMT2AKDM4E
SCHEMBL6091366 0.78 FDPS (0.55) FDPSALDH1A1SMN1; SMN2KMT2AKDM4E
SCHEMBL5673422 0.75 FDPS (0.41) FDPSALDH1A1SMN1; SMN2KMT2AKDM4E
Hydrochloric Acid SCHEMBL6092755 0.74 FDPS (0.41) FDPSALDH1A1SMN1; SMN2KMT2AKDM4E
SCHEMBL828256 0.72 FDPS (0.53) FDPSALDH1A1SMN1; SMN2KMT2AKDM4E
SCHEMBL22511537 0.72 FDPS (0.60) FDPSALDH1A1SMN1; SMN2KMT2AKDM4E
SCHEMBL25031428 0.72 FDPS (0.46) FDPSALDH1A1SMN1; SMN2KMT2AKDM4E
SCHEMBL29851369 0.71 FDPS (0.59) FDPSALDH1A1SMN1; SMN2KMT2AKDM4E
SCHEMBL828257 0.71 FDPS (0.59) FDPSALDH1A1SMN1; SMN2KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060270714-A1 Novel n-substituted 2-aminopyridine derivatives ASTRAZENECA AB (SE) 2006-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060270714-A1 Novel n-substituted 2-aminopyridine derivatives NOS1, NOS2, NOS3 FDPS 878/4885ALDH1A1 552/4885SMN1; SMN2 1200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.